Cargando…
A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
BACKGROUND: Differential diagnosis in children with signs of unprovoked inflammation can be challenging. In particular, differentiating systemic juvenile idiopathic arthritis (SJIA) from other diagnoses is difficult. We have recently validated the complex of myeloid-related proteins 8/14 (MRP8/14, a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600080/ https://www.ncbi.nlm.nih.gov/pubmed/37878193 http://dx.doi.org/10.1186/s40348-023-00168-0 |
_version_ | 1785125910052077568 |
---|---|
author | Foell, Dirk Saers, Melanie Park, Carolin Brix, Ninna Glerup, Mia Kessel, Christoph Wittkowski, Helmut Hinze, Claas Berntson, Lillemor Fasth, Anders Myrup, Charlotte Nordal, Ellen Rygg, Marite Hasle, Henrik Albertsen, Birgitte Klug Herlin, Troels Holzinger, Dirk Niederberger, Christian Schlüter, Bernhard |
author_facet | Foell, Dirk Saers, Melanie Park, Carolin Brix, Ninna Glerup, Mia Kessel, Christoph Wittkowski, Helmut Hinze, Claas Berntson, Lillemor Fasth, Anders Myrup, Charlotte Nordal, Ellen Rygg, Marite Hasle, Henrik Albertsen, Birgitte Klug Herlin, Troels Holzinger, Dirk Niederberger, Christian Schlüter, Bernhard |
author_sort | Foell, Dirk |
collection | PubMed |
description | BACKGROUND: Differential diagnosis in children with signs of unprovoked inflammation can be challenging. In particular, differentiating systemic juvenile idiopathic arthritis (SJIA) from other diagnoses is difficult. We have recently validated the complex of myeloid-related proteins 8/14 (MRP8/14, also known as S100A8/A9 complex or serum calprotectin) as a helpful biomarker supporting the diagnosis of SJIA. The results were subsequently confirmed with a commercial ELISA. However, further optimization of the analytical technology is important to ensure its feasibility for large-scale use in routine laboratory settings. METHODS: To evaluate the accuracy in identifying children with SJIA, the performance of a particle-enhanced immuno-turbidimetric assay for serum calprotectin (sCAL turbo) on an automated laboratory instrument was analyzed. Samples from 615 children were available with the diagnoses SJIA (n = 99), non-systemic JIA (n = 169), infections (n = 51), other inflammatory diseases (n = 126), and acute lymphoblastic leukemia (ALL, n = 147). In addition, samples from 23 healthy controls were included. RESULTS: The sCAL turbo assay correlated well with the MRP8/14 ELISA used in previous validation studies (r = 0.99, p < 0.001). It could reliably differentiate SJIA from all other diagnoses with significant accuracy (cutoff at 10,500 ng/ml, sensitivity 84%, specificity 94%, ROC area under curve 0.960, p < 0.001). CONCLUSIONS: Serum calprotectin analyses are a helpful tool supporting the diagnosis of SJIA in children with prolonged fever or inflammatory disease. Here, we show that an immuno-turbidimetric assay for detection of serum calprotectin on an automated laboratory instrument can be implemented in clinical laboratory settings to facilitate its use as a diagnostic routine test in clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40348-023-00168-0. |
format | Online Article Text |
id | pubmed-10600080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106000802023-10-27 A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings Foell, Dirk Saers, Melanie Park, Carolin Brix, Ninna Glerup, Mia Kessel, Christoph Wittkowski, Helmut Hinze, Claas Berntson, Lillemor Fasth, Anders Myrup, Charlotte Nordal, Ellen Rygg, Marite Hasle, Henrik Albertsen, Birgitte Klug Herlin, Troels Holzinger, Dirk Niederberger, Christian Schlüter, Bernhard Mol Cell Pediatr Research BACKGROUND: Differential diagnosis in children with signs of unprovoked inflammation can be challenging. In particular, differentiating systemic juvenile idiopathic arthritis (SJIA) from other diagnoses is difficult. We have recently validated the complex of myeloid-related proteins 8/14 (MRP8/14, also known as S100A8/A9 complex or serum calprotectin) as a helpful biomarker supporting the diagnosis of SJIA. The results were subsequently confirmed with a commercial ELISA. However, further optimization of the analytical technology is important to ensure its feasibility for large-scale use in routine laboratory settings. METHODS: To evaluate the accuracy in identifying children with SJIA, the performance of a particle-enhanced immuno-turbidimetric assay for serum calprotectin (sCAL turbo) on an automated laboratory instrument was analyzed. Samples from 615 children were available with the diagnoses SJIA (n = 99), non-systemic JIA (n = 169), infections (n = 51), other inflammatory diseases (n = 126), and acute lymphoblastic leukemia (ALL, n = 147). In addition, samples from 23 healthy controls were included. RESULTS: The sCAL turbo assay correlated well with the MRP8/14 ELISA used in previous validation studies (r = 0.99, p < 0.001). It could reliably differentiate SJIA from all other diagnoses with significant accuracy (cutoff at 10,500 ng/ml, sensitivity 84%, specificity 94%, ROC area under curve 0.960, p < 0.001). CONCLUSIONS: Serum calprotectin analyses are a helpful tool supporting the diagnosis of SJIA in children with prolonged fever or inflammatory disease. Here, we show that an immuno-turbidimetric assay for detection of serum calprotectin on an automated laboratory instrument can be implemented in clinical laboratory settings to facilitate its use as a diagnostic routine test in clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40348-023-00168-0. Springer International Publishing 2023-10-25 /pmc/articles/PMC10600080/ /pubmed/37878193 http://dx.doi.org/10.1186/s40348-023-00168-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Foell, Dirk Saers, Melanie Park, Carolin Brix, Ninna Glerup, Mia Kessel, Christoph Wittkowski, Helmut Hinze, Claas Berntson, Lillemor Fasth, Anders Myrup, Charlotte Nordal, Ellen Rygg, Marite Hasle, Henrik Albertsen, Birgitte Klug Herlin, Troels Holzinger, Dirk Niederberger, Christian Schlüter, Bernhard A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
title | A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
title_full | A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
title_fullStr | A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
title_full_unstemmed | A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
title_short | A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
title_sort | novel serum calprotectin (mrp8/14) particle-enhanced immuno-turbidimetric assay (scal turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600080/ https://www.ncbi.nlm.nih.gov/pubmed/37878193 http://dx.doi.org/10.1186/s40348-023-00168-0 |
work_keys_str_mv | AT foelldirk anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT saersmelanie anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT parkcarolin anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT brixninna anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT glerupmia anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT kesselchristoph anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT wittkowskihelmut anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT hinzeclaas anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT berntsonlillemor anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT fasthanders anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT myrupcharlotte anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT nordalellen anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT ryggmarite anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT haslehenrik anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT albertsenbirgitteklug anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT herlintroels anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT holzingerdirk anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT niederbergerchristian anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT schluterbernhard anovelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT foelldirk novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT saersmelanie novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT parkcarolin novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT brixninna novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT glerupmia novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT kesselchristoph novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT wittkowskihelmut novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT hinzeclaas novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT berntsonlillemor novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT fasthanders novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT myrupcharlotte novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT nordalellen novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT ryggmarite novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT haslehenrik novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT albertsenbirgitteklug novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT herlintroels novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT holzingerdirk novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT niederbergerchristian novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings AT schluterbernhard novelserumcalprotectinmrp814particleenhancedimmunoturbidimetricassayscalturbohelpstodifferentiatesystemicjuvenileidiopathicarthritisfromotherdiseasesinroutineclinicallaboratorysettings |